Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Severe COVID-19
NCT04288102Phase 2Completed
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Mar 2020
- Primary completion
- May 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in coronavirus disease 2019 (COVID-19), sponsored by The Fifth Medical Center of the PLA General Hospital. Started Mar 2020; status: completed.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04288102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04288102.